UniQure said Monday that plans to seek approval for its Huntington’s disease treatment with the Food and Drug Administration ...

In the late 20th century, the United States made a bet that it could offshore manufacturing to countries with cheaper labor, ...

STOCKHOLM, Sweden, March 3, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that Organon has discontinued the development of a preclinical drug candidate for polycystic ovarian syndrome ...

Belgian drugmaker UCB has entered into an agreement to licence Antengene's experimental autoimmune disease therapy ATG-201 ...

The FDA believes that an experimental therapy for Huntington’s disease from UniQure wasn't providing benefit for patients, a ...

Major biotech and pharmaceutical companies are asking the Trump administration to rescind two proposals seeking to align US ...

The continuous movement of the vocal cords weakens and eventually stops as laryngeal cancer progresses. Researchers have, for ...

Phil Low, a Purdue University scholar and entrepreneur who developed cancer therapies and founded seven companies, has died ...

Tevogen ('Tevogen Bio Holdings Inc.” or 'Company”) (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent ('LoI”) to evaluate a potential ...

The EMA and FDA have published a set of 10 'common principles' that should be taken into account when using AI in the development of medicines. The list has emerged as the adoption of AI among ...

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the ...

The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and ...